gastric cancer
Conditions
Interventions
None listed
Sponsors
Osaka International Cancer Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Gastric cancer was diagnosed by histological examination of an endoscopic biopsy specimen. 2) The lesion does not meet the indication of endoscopic resection but surgical resection. 3) The tumor has been diagnosed as potentially resectable by comprehensive diagnosis using endoscopy and preoperative imaging (endoscopy or abdominal/pelvic CT). 4) The age of subjects are over 20 years old. 5) ECOG-PS is 0, 1, or 2. 6) All of the following conditions are met. (All test items are used the latest test values taken within 56 days before registration. Testing on the same day of the week 8 weeks before the registration date is acceptable.) 1. White blood cell count >=3,000/mm3 2. Platelet count >=100,000/mm3 3. AST<=100IU/L, ALT<=100IU/L 4. Total bilirubin <=2.0 g/dl 5. Serum creatinine <=1.5mg/dl 6. Written consent has been obtained from the subject to participate in the study.
Exclusion criteria
Exclusion criteria: 1) Subjects with distant metastasis to other organs or peritoneal dissemination 2) Subjects who have previously undergone intra-abdominal surgery for other diseases and are expected to have severe adhesions. 3) The subjects have active multiple cancers (synchronous multiple cancers and metachronous multiple cancers with a disease-free period of 5 years or less). However, the lesions equivalent to carcinoma in situ (carcinoma in situ) or intramucosal cancer that can be cured by local treatment are not included in active double cancer. 4) Women who may be pregnant or are breastfeeding. 5) Subjects with mental illness or psychiatric symptoms . 6) Subjects receiving continuous systemic administration of steroids (orally or intravenously). 7) History of myocardial infarction within 6 months or unstable angina. 8) Concomitant with poorly controlled hypertension. 9) Currently being treated with insulin or having uncontrolled diabetes. 10) Subjects have a respiratory disease that requires continuous oxygen administration. 11) Other patients deemed unsuitable as subjects by the research director
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total complication rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Completion rate of the robotassisted laparoscopic or laparoscopic gastrectmy, operative time, blood loss, number of lymph nodes dissected, length of postoperative hospital stay, postoperative pain evaluated by VAS, medical costs, relase free survival , overall survival | — |
Countries
Japan
Contacts
Public ContactNaoki Shinno
Osaka International Cancer Institute Division of gastroenterological surgery
Outcome results
None listed